Published in FEBS Lett on July 25, 1983
A system for shotgun DNA sequencing. Nucleic Acids Res (1981) 52.99
Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science (1977) 9.28
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 6.14
Chemical synthesis of genes for human insulin. Proc Natl Acad Sci U S A (1978) 6.09
Human leukocyte interferon produced by E. coli is biologically active. Nature (1980) 5.86
Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci U S A (1979) 4.72
Synthesis of oligonucleotides on cellulose by a phosphotriester method. Nucleic Acids Res (1980) 4.00
Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature (1979) 3.80
Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Res (1980) 3.75
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J (1986) 2.62
Synthesis of oligonucleotides on cellulose. Part II: Design and synthetic strategy to the synthesis of 22 oligodeoxynucleotides coding for gastric inhibitory polypeptide (GIP). Nucleic Acids Symp Ser (1980) 2.49
The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun (1979) 2.26
Conformational stability of alternating d (CG) oligomers in high salt solution. Nucleic Acids Res (1981) 2.00
Adenovirus DNA replication in vitro: site-directed mutagenesis of the nuclear factor I binding site of the Ad2 origin. Nucleic Acids Res (1985) 1.77
Lysis gene of bacteriophage MS2 is activated by translation termination at the overlapping coat gene. J Mol Biol (1987) 1.60
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56
Chemical synthesis and expression of a calmodulin gene designed for site-specific mutagenesis. Biochemistry (1985) 1.55
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients. Ann Oncol (2011) 1.54
High-affinity binding of a synthetic heptaglucoside and fungal glucan phytoalexin elicitors to soybean membranes. FEBS Lett (1990) 1.50
Time course of the increase in the myocardial slow inward current after a photochemically generated concentration jump of intracellular cAMP. Proc Natl Acad Sci U S A (1983) 1.41
Synthesis, structure, and reactivity of adenosine cyclic 3',5'-phosphate benzyl triesters. J Med Chem (1977) 1.34
DNA hairpin loops in solution. Correlation between primary structure, thermostability and reactivity with single-strand-specific nuclease from mung bean. Nucleic Acids Res (1991) 1.26
Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus. J Virol (1989) 1.12
Molecular cloning and characterization of a complete DNA copy of potato spindle tuber viroid RNA. Nucleic Acids Res (1982) 1.04
Oligonucleotide directed mutagenesis: selection of mutants by hemimethylation of GATC-sequences. Mol Gen Genet (1984) 1.03
Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. Eur J Clin Invest (2002) 1.01
Vasopressin and oxytocin mRNA regulation in the rat assessed by hybridization with synthetic oligonucleotides. J Biol Chem (1983) 1.00
Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene. Biochemistry (1980) 0.97
Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) (2002) 0.97
Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3. Clin Exp Immunol (1995) 0.97
Effect of preformed correct tertiary interactions on rapid two-state tendamistat folding: evidence for hairpins as initiation sites for beta-sheet formation. Biochemistry (1997) 0.96
Degradation of rRNA in interferon-treated vaccinia virus-infected cells. J Biol Chem (1984) 0.95
An ATP-dependent inhibition of protein synthesis in ascites cell extracts by wheat germ protein. Biochim Biophys Acta (1977) 0.94
Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal. Biochemistry (1988) 0.94
Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes (1999) 0.93
Alloimmunization as a strategy for vaccine design against HIV/AIDS. AIDS Res Hum Retroviruses (2000) 0.93
Simultaneous stability of short alternating Z and B helices in synthetic DNA concatamers. Nucleic Acids Res (1982) 0.93
Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells. J Biol Chem (1981) 0.92
Native-like beta-structure in a trifluoroethanol-induced partially folded state of the all-beta-sheet protein tendamistat. J Mol Biol (1996) 0.92
Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest (2002) 0.91
New applications of urinary nucleoside markers. Recent Results Cancer Res (1983) 0.89
Primary structures of new 'iso-hirudins'. FEBS Lett (1989) 0.89
Rapid automated synthesis via diisopropyl phosphoramidite in situ activation. Chemical synthesis and cloning of a calmodulin gene. Biochem Cell Biol (1986) 0.87
2'-5'-Linked oligo(adenylic acid) and its analogs. A new class of inhibitors of mRNA methylation. J Biol Chem (1982) 0.87
Partial characterization of the mRNA that codes for enkephalins in bovine adrenal medulla and human pheochromocytoma. Proc Natl Acad Sci U S A (1982) 0.87
Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Res (1983) 0.87
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial. Eur J Cancer (2014) 0.86
Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods. Food Chem Toxicol (2006) 0.86
Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study. Diabetes Care (2000) 0.86
Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem Cell Biol (1990) 0.86
Elevated urinary excretion of beta-aminoisobutyric acid and exposure to inorganic lead. Arch Environ Health (1987) 0.85
Applications of urinary nucleosides in cancer diagnosis and cancer management. Cancer Detect Prev (1983) 0.85
Effects of CYP induction by rifampicin on tamoxifen exposure. Clin Pharmacol Ther (2012) 0.84
Transfer RNA breakdown products in the urine of asbestos workers. Cancer Detect Prev (1984) 0.84
Expression in Escherichia coli of a chemically synthesized gene for a "mini-C" analog of human proinsulin. Gene (1981) 0.83
Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline. Crit Rev Oncol Hematol (2012) 0.82
Inhibition of vaccinia mRNA methylation by 2',5'-linked oligo(adenylic acid) triphosphate. Proc Natl Acad Sci U S A (1981) 0.82
Transcription initiation at the tet promoter and effect of mutations. Nucleic Acids Res (1988) 0.82
The effects of adenosine- and guanosine 3',5'-phosphoric acid benzyl esters on guinea-pig ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.82
Accumulation of methyl-deficient rat liver messenger ribonucleic acid on ethionine administration. Biochemistry (1980) 0.81
Limitation of reticulocyte transfer RNA in the translation of heterologous messenger RNAs. Biochemistry (1976) 0.81
Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells. Antisense Nucleic Acid Drug Dev (2000) 0.81
The cytopathic 18f strain of Hepatitis A virus induces RNA degradation in FrhK4 cells. Arch Virol (2003) 0.81
Gene synthesis. Adv Biochem Eng Biotechnol (1988) 0.80
A mechanism of estrogen action on gene expression at the level of translation. Cancer Res (1976) 0.80
Modulation of the synthesis in vitro of a hormone-induced protein by transfer RNA. Nature (1976) 0.80
Inhibition of mitochondrial protein synthesis by nitrofurantoin in rat and goat liver. Biochem Pharmacol (1974) 0.80
Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. Cancer Res (1986) 0.79
Transcriptional induction of proto-oncogene fos by HSV-2. Biochem Biophys Res Commun (1987) 0.79
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer (2011) 0.79
Inhibitor of transfer ribonucleic acid methylase in the differentiating slime mold Dictyostelium discoideum. J Bacteriol (1970) 0.79
Transfer RNA methylases during sea urchin embryogenesis. Biochim Biophys Acta (1971) 0.79
[Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease]. Ned Tijdschr Geneeskd (2005) 0.79
Inotropic and electrophysiological effects of 8-substituted cyclic AMP analogues on guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.79
Protein synthesis in vitro in a system from plant mitochondria. Biochem J (1973) 0.79
A novel splice variant of the cell death-promoting protein BAX. J Biol Chem (1998) 0.79
A transfer RNA-dependent protein synthesizing system from Ehrlich ascites extracts. Biochim Biophys Acta (1975) 0.79
Lysine transfer RNA2 is the major target for L-ethionine in the rat. Biochemistry (1978) 0.78
Methylation of transfer RNA during transformation of human lymphocytes by phytohemagglutinin. Biochem Biophys Res Commun (1973) 0.78
On the chemistry of RNA degradation by Fe.bleomycin. Bioorg Med Chem (1997) 0.78
Effect of vitamin E succinate and a cAMP-stimulating agent on the expression of c-myc and N-myc and H-ras in murine neuroblastoma cells. Int J Dev Neurosci (1991) 0.78
Morphology of interdentally stripped enamel one year after treatment. J Clin Orthod (1989) 0.78
Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.77
Chemical synthesis of an effective inhibitor of protein synthesis in eukaryotic cells: pppA2'-5'A2'-5'A and some analogues. Nucleic Acids Symp Ser (1980) 0.77
Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. 1977. Biotechnology (1992) 0.77
Differences in the transfer RNA methyltransferases from normal rat liver and Novikoff hepatoma. Biochim Biophys Acta (1973) 0.77
A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid. Antisense Nucleic Acid Drug Dev (2000) 0.77
Studies on the intravenous pharmacokinetics in rabbit and in vitro protein binding of two new salts of erythromycin: erythromycin maltobionate and erythromycin fumarate. Biopharm Drug Dispos (1992) 0.77
Inhibition of ovalbumin mRNA translation by 7-methylguanosine-5'-phosphate. Biochem Biophys Res Commun (1976) 0.77
Agents of modulation of the transfer RNA methylases. Cancer Res (1971) 0.77